{'Year': '2016'}
Pharmacogenetics in Neurodegenerative Diseases: Implications for Clinical Trials.
Pharmacogenetics has become extremely important over the last 20 years for identifying individuals more likely to be responsive to pharmacological interventions. The role of genetic background as a predictor of drug response is a young and mostly unexplored field in neurodegenerative diseases.